The largest database of trusted experimental protocols

Anti pcsk9 neutralizing antibody

Manufactured by BPS Biosciences

Anti-PCSK9 neutralizing antibody is a laboratory product that binds to and neutralizes the PCSK9 protein. PCSK9 is involved in regulating low-density lipoprotein (LDL) cholesterol levels in the body.

Automatically generated - may contain errors

3 protocols using anti pcsk9 neutralizing antibody

1

PCSK9 Inhibitor Binding and Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemical reagents were obtained from Sigma-Aldrich unless otherwise specified. Anti-PCSK9 neutralizing antibody was from BPS Biosciences (San Diego, CA). Alirocumab was from Sanofi (Paris, France) and Regeneron Pharmaceuticals, Inc. (Tarrytown, NY). Evolocumab was from Amgen (Thousand Oaks, CA). Trastuzumab was from Genentech (South San Francisco, CA). All luminescence readings were performed on a Glomax Discover Detection System (Promega Corp., Madison, WI). EC50 calculations were performed using GraphPad Prism (version 6.03).
+ Open protocol
+ Expand
2

PCSK9-mediated LDLR Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
LgBiT-LDLR-expressing HEK293 cells were plated at 10,000 cells/well in a 96-well plate in 100 µl of DMEM complete media (containing 10% FBS) and incubated in a cell culture incubator (37°C, 5% CO2, humidified atmosphere) overnight. Then the medium was removed and replaced with Nano-Glo Luciferase Assay Substrate diluted into Opti-MEM. To a subset of wells, Opti-MEM was added that contained PCSK9-SmBiT, for a final concentration of 0.8 µg/ml; other wells received Opti-MEM only for NanoGlo substrate background analysis. Luminescence was monitored every minute for 30 min. Then anti-PCSK9 neutralizing antibody (BPS Biosciences) was spiked into a subset of wells, for a final concentration of 15 nM, and luminescence readings were resumed.
+ Open protocol
+ Expand
3

Quantifying PCSK9 Antibody Binding in LgBiT-LDLR HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LgBiT-LDLR-expressing HEK293 cells were plated at 10,000 cells/well in a 96-well plate in 100 µl of DMEM complete media (containing 10% FBS), and incubated in a cell culture incubator overnight. Then the medium was removed and replaced with 25 µl of Opti-MEM (Thermo Fisher Scientific), containing 2× PCSK9-SmBiT for a final concentration of 0.8 µg/ml and 25 µl of Opti-MEM containing a 2× antibody titration. Alirocumab and evolocumab were tested starting at 60 nM, and anti-PCSK9 neutralizing antibody (BPS Biosciences) and nonspecific control antibody, trastuzumab, starting at 20 nM. The reaction was incubated for 1 h; then 12.5 µl of 5× Nano-Glo Luciferase Assay Substrate (Promega) diluted into Opti-MEM was added to the reaction. The luminescence was measured after a 15 min incubation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!